SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Pastimes : Shopping For The Ultimate Bargains -- Ignore unavailable to you. Want to Upgrade?


To: sandintoes who wrote (2068)11/1/2008 3:04:46 PM
From: stock leader  Read Replies (1) | Respond to of 2203
 
with GNLB being bought out at 400% above closing price, other cash-value biotechs are ripe for takeover (in other words, biotechs with no debt). INHX has net-cash of $30 mill on hand versus market value of stock of $12 mill. makes sense for the bigger pharmas to scoop up these bargains----they buyout the brains, get the intellectual property for free along with $30 mill in un-encumbered cash... can't find better value than that!